Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology
The DOI matches its Crossref record.
Abstract
The discontinuation of tricyclic antidepresants (TCAs) produces a broad array of symptoms which can be grouped to form 4 categories or syndroms: (1) general somatic distress with anxiety or agitation, (2) sleep disturbance characterized by excessive, vivid dreaming and initial or middle insomnia, (3) movement disorder, and (4) behavioral activation on a continuum to mania. Syndromes (1H3) may be due to withdrawal-induced cholinergic overdrive at peripheral (e.g. the gastrointestinal system) and central (e.g. the gigantocellular tegmental field and the mesocortical, nigrostriatal and mesolimbic tracts) sites. The cholinergic overdrive hypothesis is supported by reports that anticholinergic agents produce tolerance, all TCAs block the physiological effects of acetylcholine and competitively displace radiolabeled muscarinic receptor antagonists in vitro and antidepressant withdrawal symptoms respond to centrally active antimuscarinics. Withdrawal-triggered abnormalities in the interaction of cholinergic and monoaminergic systems may contribute to the development of TCA-withdrawal associated mania but the pathophysiology of this syndrome remains unknown. The development of these syndromes indicates that TCAs can produce heuristically important modifications in cholinergic systems and that they might be used to model those aspects of the pathophysiology of depression which may have a cholinergic component. Phenomenological, physiological, biochemical and receptor binding variables which are pertinent to the biology of depression and partially regulated by cholinergic mechanisms are prime targets for strategies employing TCAs to supersensitize cholinergic systems. Both clinical and basic aspects of TCA withdrawal phenomena are discussed in detail. This article reviews signs and symptoms produced by the withdrawal of tricyclic antidepressants (TCAs), the management and pathophysiology of TCA-withdrawal phenomena and the use of TCAs and classical antimuscarinic agents to model cholinergic abnormalities which may be involved in the pathogenesis of depression. The phenomenology of TCA withdrawal syndromes is first illustrated using case examples. Evidence that TCAs produce cholinergic system supersensitivity and their withdrawal cholinergic overdrive is then presented. The “cholinergic overdrive hypothesis,” does not explain TCA withdrawal-induced hypomania. It is possible, however, that withdrawal of TCAs mobilizes monoaminergic pathways via the activation of cholinergic neurons. Data consistent with this possibility are briefly presented. Finally, the use of TCAs and related drugs to model the pathophysiology of depression is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Sindrup, S. H., Gram, L. F., Brøsen, K., Eshøj, O., & Mogensen, E. F. (1990) · Pain · doi:10.1016/0304-3959(90)91157-e · Cited by 463
Anderson, I. M., Nutt, D. J., & Deakin, J. F. W. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400101 · Cited by 310
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
Metadata
- Authors
- DILSAVER, S. C., GREDEN, J. F., & SNIDER, R. M.
- Venue
- International Clinical Psychopharmacology
- Published
- 1987-01
- Volume
- 2
- Issue
- 1
- Pages
- 1-19
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2030509783
- Cited by
- 81
- References
- 0
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology. https://app.cochat.ai/papers/10.1097/00004850-198701000-00001
- The paper
- DILSAVER, S. C., GREDEN, J. F., & SNIDER, R. M. (1987). Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-198701000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.